At Manetco, We are thrilled to highlight our collaboration with ConvEyXO, a company committed to promoting healthier lifespans through the development of anti-inflammaging and anti-inflammatory therapeutics. By unlocking the transformative power of extracellular vesicules (EVs), ConvEyXO is addressing high-prevalence unmet medical needs.
To achieve the required EV loading performance without damaging these vital vesicles, ConvEyXO utilizes nanofluidic technology developed by XomeXbio. At Manetco, we had the privilege of designing and developing robust microfluidic equipment that processes EV loading with precise flow control and GMP compliance capabilities.
Working closely with the ConvEyXO team, we identified the main components necessary for the process, such as specialized pumps. We began with a minimum viable product (MVP) of the equipment, incorporating essential components to validate performance for the microfluidic process. This collaboration evolved into the selection and development of automated equipment that now efficiently runs all their experiments.
A big thank you to the ConvEyXO team for this fantastic collaboration! We're proud to be part of this journey towards revolutionizing EV manufacturing and loading.
#Manetco #ConvEyXO #Collaboration #Microfluidics #ExtracellularVesicles #Innovation #Biotechnology
Proud to Support ConvEyXO in Revolutionizing Anti-Inflammatory Therapeutics